ASH Annual Meeting & Exposition: Multiple Myeloma | Conference

Deepu Madduri, MD, on the Future Potential of Therapies to Treat Multiple Myeloma
January 20, 2021

The expert in multiple myeloma highlighted the research which she was most excited to see presented at the ASH Annual Meeting & Exposition.

Guido Lancman, MD, on Next Steps for a Study of IVIG in Patients with Multiple Myeloma Receiving Daratumumab
January 11, 2021

Hypogammaglobulinemia was found to be nearly universal for patients with multiple myeloma during treatment with daratumumab, suggesting a role for intravenous immunoglobulin.

Lisa La on the Next Steps for a Study of Diabetes in Patients with Multiple Myeloma
January 07, 2021

The director of clinical research in the Center for Cancer Care at White Plains Hospital spoke about what she intends to evaluate for a patient population with multiple myeloma and diabetes moving forward.